CONFERENCE ON BREAST AND PROSTATE CANCER

乳腺癌和前列腺癌是最近三种疾病中的两种 被指定为SPORE资助机制的高优先目标。 这 会议包括来自这些指定孢子的研究人员 中心;沿着许多其他当前的研究人员，以促进最大的 互动与交流。 这是一次独特的会议， 采用比较和多学科方法，揭示工作机制 在两种最致命的癌症中 乳腺癌 和前列腺在它们对性的依赖性上有着独特的联系 类固醇激素的发病和恶性进展。 最近的研究 也开始探索家族性疾病机制的潜在共性， 易感性，各自性类固醇受体的突变，致癌基因， 和抑制基因，生长因子的局部控制机制， 转移扩散到远处的机制。 会议将 强调这些领域对话，以改进诊断， 向新的化学，激素和生物疗法的两个运动 疾病 会议将被设计为交叉施肥的想法在主题 从基本的细胞和分子生物学到基于 对乳腺和前列腺肿瘤生物学和利用的新认识 新的治疗剂。

Breast and prostate cancers are two of the three diseases recently designated as high priority targets of the SPORE funding mechanisms. This conference includes researchers from each of these designated SPORE centers; along with many other current investigators, to promote maximal interaction and exchange. This is a unique meeting dedicated to a comparative, multidisciplinary approach in uncovering mechanisms at work in two of the deadliest cancers of men and women. Cancers of the mammary and prostate glands are uniquely linked in their dependence upon sex steroid hormones for onset and malignant progression. Recent studies have also begun to explore potential commonalities in mechanisms of familial pre-disposition, mutations of respective sex steroid receptors, oncogenes, and suppressor genes, mechanisms of local control by growth factors and mechanisms of metastatic spread to distant sites. The meeting will highlight dialogue in these areas with a goal of improved diagnosis and movement toward new chemo-,hormonal and biological therapies of the two diseases. Sessions will be designed to cross fertilize ideas in topics ranging from basic cell and molecular biology to new clinical trials based on new understanding of breast and prostate tumor biology and utilization of new therapeutic agents.